<DOC>
	<DOCNO>NCT00592683</DOCNO>
	<brief_summary>This 12 week , double blind study omega-3 fatty acid vs. placebo adjunctive open-label aripiprazole treatment child adolescent ( age 6-17 ) meet DSM-IV criterion bipolar disorder ( BPD ) ( currently manic mixed ) . Specific hypotheses follow : Hypothesis 1 : Omega-3 fatty acid well-tolerated efficacious treatment child adolescent BPD Hypothesis 2 : The total dose aripiprazole lower subject receive active omega-3 treatment</brief_summary>
	<brief_title>Omega-3 Fatty Acid Adjunctive Open-Label Aripiprazole Treatment Bipolar Disorder Children Adolescents</brief_title>
	<detailed_description>Initial clinical evidence suggest omega-3 fatty acid EPA ( eicosapentaenoic acid ) and/or DHA ( docosahexaenoic acid ) may play therapeutic role management mood disorder . EPA essential fatty acid , metabolize DHA component human diet fish consume . Aripiprazole novel second general antipsychotic seem function partial agonist dopamine D2 serotonin 5-HT 1A receptor well antagonist serotonin 5-HT 2A receptor . Since favorable adverse event profile adult , attractive choice treatment youth bipolar disorder proven efficacious . Although pilot research show omega-3 fatty acid monotherapy treatment result improvement manic symptom , improvement less dramatic observed trial antipsychotic . We test safety efficacy omega-3 fatty acid versus placebo adjunctive treatment open-label aripiprazole child adolescent bipolar disorder . The propose study include 1 ) use 12-week design document response rate 2 ) careful assessment safety tolerability</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>1 . Male female subject , 617 year age 2 . Subject DSMIV diagnosis bipolar I , bipolar II , bipolar spectrum disorder currently display manic , hypomanic , mixed symptom ( without psychotic feature ) 3 . Subject legal representative level understanding sufficient communicate intelligently investigator study coordinator , cooperate test examination require protocol 4 . Subject legal representative must consider reliable 5 . Subject his/her authorized legal representative must understand nature study . The subject 's authorized legal representative must sign informed consent document subject must sign informed assent document 6 . Subject must initial score YoungMania Rating Scale ( YMRS ) least 20 7 . Subject must able participate mandatory blood draw 8 . Subject must able swallow pill 9 . Subjects comorbid Attention Deficit Hyperactivity Disorder ( ADHD ) , Oppositional Defiant Disorder ( ODD ) , Conduct Disorder ( CD ) , Obsessive Compulsive Disorder ( OCD ) , Pervasive Developmental Disorders ( PDD ) , anxiety depressive disorder allow participate study provide meet exclusionary criterion 10 . For concomitant therapy use treat ADHD , subject must stable dose medication 1 month prior study enrollment . The dose ADHD therapy may change throughout duration study . 1 . Investigator his/her immediate family ; define investigator 's spouse , parent , child , grandparent , grandchild 2 . Serious , unstable illness include heptic , renal , gastroenterological , respiratory , cardiovascular ( include ischemic heart disease ) , endocrinologic , neurologic , immunologic , hematologic disease 3 . Uncorrected hypothyroidism hyperthyroidism 4 . History sensitivity omega3 fatty acid . A nonresponder history intolerance omega3 fatty acid , treatment adequate dos determine clinician . 5 . Severe allergy multiple adverse drug reaction . 6 . Nonfebrile seizure without clear resolve etiology 7 . DSMIV substance ( except nicotine caffeine ) dependence within past 6 month 8 . Judged clinically serious suicidal risk 9 . Any concomitant medication primarily central nervous system activity specify Concomitant Medication portion protocol . 10 . Current diagnosis schizophrenia 11 . Pregnant nursing female</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>bipolar disorder</keyword>
	<keyword>fish oil</keyword>
	<keyword>aripiprazole</keyword>
	<keyword>child</keyword>
</DOC>